Jeff Ellsworth Email & Phone Number
Chief Executive Officer
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Jeff Ellsworth Location
- Bedford, MA, US
Jeff Ellsworth Work
- 2023 -now Chief Executive Officer @ Halide Biologics, Inc.
- 2020 -now Founder and Partner @ Stellar Research and Development LLC
- 2020 -2023 Chief Scientific Officer @ Recardia Therapeutics, Inc
- 2016 -2020 Senior Director, External Sciences @
- 2013 -2016 Founder and Partner @ Stellar Research and Development, LLC
- 2015 -2015 Chief Executive Officer @ Avastus Preclinical Services LLC
- 2014 -2015 Chief Scientific Officer @ Avastus Preclinical Services LLC
- 2012 -2013 Senior Director @
- 2011 -2012 Founder @ Ellsworth Biotech/Pharma Consulting
- 2010 -2011 Senior Director, New Opportunities @ Eleven Biotherapeutics
- 2009 -2009 Director, Target Validation and Realization @ Ambrx
Jeff Ellsworth Education
- Stanford University
Postdoctoral (Dept of Biological Sciences)
1987-1988 - Stanford University School of Medicine
Postdoctoral (Lipoprotein receptors, lipid metabolism)
1983-1985 - University of Cincinnati College of Medicine
Ph.D. (Pharmacology and Cell Biophysics)
1979-1982 - Indiana University Bloomington
BS (Chemistry)
1976-1978
Jeff Ellsworth Skills
- Inflammation
- Pharmacology
- Autoimmunity
- Osteoarthritis
- Lipid Metabolism
- Project Teams
- Competitive Intelligence
- ELISA
- Cell
- Pharmaceutical Research
- In Vivo
- Team Leadership
- Biotechnology
- Assay Development
- Aggregation
- Gastrointestinal
- Hepatology
- Philadelphia
- Gene Expression
- Acid
- Induction
- Therapeutic Areas
- Foundation
- Cho
- Methylation
- Investigation
- ERD
- Art Exhibitions
- Metaphase
- Fibre Channel
- Edition
- Crystal
- Non Clinical
- ACAD
- Assessment
- Medicine
- Thyroid
- Simultaneous
- Product Development
- Manufacturing
- Hepatitis C
- Liver
- Profiles
- Clinical Development
- Purification
- Pacific
- Financial Transactions
- Pancreatic
- Abstraction
- Pharmaceutics
- Shape
- Identifying New Opportunities
- Advertising
- Training
- Plasma Physics
- Biotherapeutics
- Dna Replication
- Written
- Affinity
- Strategic Alliances
- Curriculum Design
- Management
- Dependent
- Analysis
- Circulation
- Density
- Utility
- Feasibility Studies
- Mammalian
- Absorption
- Maestro
- Reports
- Conceived
- Press
- Nimbus
- Thompson
- Media
- Microsoft Exchange
- Drug Resistance
- Iowa
- Hydrophobic Interaction
- Coordinated
- Harmony
- Intellectual Property
- Clinical Trials
- Manuscript
- Gene Regulation
- Lipids
- Evaluations
- Strategies
- Element
- Business Alliances
- SCI Clearance
- Sun Microsystems
- Coagulation
- Antibodies
- Start Up Ventures
- Window
- Atherosclerosis
- Networking
- Conferences
- Isoelectric Focusing
- Stroke
- Pipelines
- Treatment
- Heart Failure
- Mc
- Decision Trees
- Transcription
- Cancer
- Mature
- Cellular Communications
- Strategy
- GPC
- Separation
- Autodesk Inventor
- Differentiation
- High Density
- Collaborating
- Situational Leadership
- Exciting
- Meyer
- Fox
- Viability
- Piloting
- Biology
- Scientific
- Facilitation
- Patents
- Health and Safety
- Net
- Symposium
- Data Encryption Standard
- SAP R/3
- Chromatography
- Drug Development
- Russia
- Moscow
- Regulations
- Sales
- Liver Disease
- Annotation
- Cell Culture
- Executive Development
- Expression
- Blocks
- Regulatory Requirements
- House
- Purchase Orders
- Pathway
- Lead Development
- Characterization
- Pfizer
- Structural Engineering
- In Licensing
- Transient
- Infection
- Structure
- Measurements
- Business Services
- Human Services
- Plate
- Patient
- Timelines
- Translational Science
- Blood
- Department of Health
- Molecular Biology
- A2
- Proliferation
- Efficacy
- Community
- Differential
- Interference
- American
- Executive Management
- Cholesterol
- Abundance
- Gene Transfer
- Factor
- Auto
- Realization
- Mac
- Humans
- Academic Research
- Rheumatology
- Clinical Research
- Google Groups
- Microsoft Word
- Ml
- Logic Synthesis
- Macrophages
- Sourcing
- Materials Management
- Mechanism
- Indiana
- Interventions
- Commercial Real Estate
- Radiographic Testing
- Project Leaders
- Immunotherapy
- Maintenance and Repair
- Data Storage
- Aspen HYSYS
- Dissociation
- Diabetes
- Business Partnering
- Project
- Arthritis
- Detection
- JavaScript
- In Vitro
- Scientific Background
- Consulting
- Portfolio Management
- Fed
- Sle
- Public Health
- Scientific Review
- Monitors
- Protein Science
- Orthopaedic
- Business Development
- Disease
- Pain Management
- Therapists
- Research
- Book Chapters
- Cardiovascular
- Pigs
- Biologics
- Conceptual Modeling
- Protein Chemistry
- Occlusion
- Road
- Data Analysis
- Project Management
- Vascular
- Market
- Federation
- Palo Alto
- Rats
- Adenovirus
- Patent Applications
- Writing
- Serum
- Cartilage
- Resume
- Contractual Agreements
- Value Propositions
- Phase Ii
- Rate
- Growth Factors
- Immunoblotting
- Isolation
- Pharmaceutical Industry
- Communication
- Academic
- Data Transformation
- Res
- Western Blotting
- Binding
- International
- Neuroscience
- Targeted Advertising
- Peer Reviews
- Sds Page
- Biophysics
- Biochemistry
- Collagen
- Target Identification
- Wang
- Pro*c
- Hardware Description Language
- Gel
- Evaluation
- Gastroenterology
- Metabolism
- Modulation
- Abstracts
- Occupation
- Biomarker Development
- Treating
- Evidence
- Congress
- R
- Thrombosis
- Stimulation
- Licensing
- Rush
- Atlas
- Start Ups
- San Diego
- Gao
- Location
- E. Coli
- Boston
- Project Reviews
- New Opportunities
- Hematology
- Risk
- Aid
- Hp Enterprise Solutions
- Drug Delivery
- Cardiovascular Biology
- Blocking
- Chemistry
- Rationale
- Staff Development
- Publications
- Wolf
- Department of Transportation
- Strength Training
- Public Speaking
- Injury
- Receptors
- Informatics
- C
- Immunology
- Scientists
- Customer Service
- Frequency
- Seattle
Jeff Ellsworth Summary
- Jeff Ellsworth, based in Bedford, MA, US, is currently a Chief Executive Officer at Halide Biologics, Inc.. Jeff Ellsworth brings experience from previous roles at Stellar Research and Development LLC, Recardia Therapeutics, Inc, Homology Medicines Inc. and Stellar Research and Development, LLC. Jeff Ellsworth holds a 1987 - 1988 Postdoctoral in Dept of Biological Sciences @ Stanford University. With a robust skill set that includes Inflammation, Pharmacology, Autoimmunity, Osteoarthritis, Lipid Metabolism and more. Jeff Ellsworth has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Jeff Ellsworth?
Find contact details for 700 million professionals.
Others Named Jeff Ellsworth
Jeff Ellsworth
Partner
Greenwich, CT, US
Jeff Ellsworth
Director Intellectual Property North America
Hesston, KS, US
Jeff Ellsworth
Chief Executive Officer
Bedford, MA, US
Jeff Ellsworth
IT Manager
Hopkinton, NH, US
Jeff Ellsworth
IT Manager, System Administration
Edmond, OK, US
Jeff Ellsworth
Sales Rep
Barrie, ON, CA
Jeff Ellsworth
President
Boulder, CO, US
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co